Publication: Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study.
Loading...
Identifiers
Date
2018
Authors
Coronado, Pluvio J
Rychlik, Agnieszka
Martínez-Maestre, Maria A
Baquedano, Laura
Fasero, María
García-Arreza, Aida
Morales, Sara
Lubian, Daniel M
Zapardiel, Ignacio
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
To assess the impact of lymph node dissection (LND) on morbidity, survival, and cost for intermediate-risk endometrial cancers (IREC). A multicenter retrospective cohort of 720 women with IREC (endometrioid histology with myometrial invasion Both study groups were homogeneous in demographic data and pathologic results. The mean follow-up in patients free of disease was 61.7 months (range, 12.0-275.5). DFS (hazard ratio [HR]=1.34; 95% confidence interval [CI]=0.79-2.28) and OS (HR=0.72; 95% CI=0.42-1.23) were similar in both groups, independently of nodes count. In LND group, positive nodes were found in 10 cases (5.6%). Operating time and late postoperative complications were higher in LND group (p Systematic LND in IREC has no benefit on survival, although it does not show an increase in perioperative morbidity or global cost.
Description
MeSH Terms
Adult
Aged
Aged, 80 and over
Cost-Benefit Analysis
Endometrial Neoplasms
Female
Humans
Lymph Node Excision
Lymphatic Metastasis
Matched-Pair Analysis
Middle Aged
Morbidity
Neoplasm Staging
Postoperative Complications
Retrospective Studies
Risk Factors
Severity of Illness Index
Survival Analysis
Treatment Outcome
Uterine Neoplasms
Aged
Aged, 80 and over
Cost-Benefit Analysis
Endometrial Neoplasms
Female
Humans
Lymph Node Excision
Lymphatic Metastasis
Matched-Pair Analysis
Middle Aged
Morbidity
Neoplasm Staging
Postoperative Complications
Retrospective Studies
Risk Factors
Severity of Illness Index
Survival Analysis
Treatment Outcome
Uterine Neoplasms
DeCS Terms
CIE Terms
Keywords
Costs and Cost Analysis, Endometrial Neoplasms, Lymph Node Excision, Morbidity, Risk Factors, Survival